There are 2949 resources available
168MO - GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status
Presenter: Theresa Link
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
169MO - Development and validation of a magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with breast cancer: A multicenter cohort study
Presenter: Herui Yao
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
1027MO - ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)
Presenter: Ulka Vaishampayan
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
LBA42 - POD1UM-202: Phase II study of retifanlimab in patients (pts) with squamous carcinoma of the anal canal (SCAC) who progressed following platinum-based chemotherapy
Presenter: Sheela Rao
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1023MO - AMC 095: A report of nivolumab (nivo) in advanced HIV associated solid tumours (ST)
Presenter: Lakshmi Rajdev
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1024MO - A phase I/II MATINS trial: Part 1 pharmacokinetic, safety and efficacy results of Clever-1 blockade in advanced cancer
Presenter: Petri Bono
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1025MO - First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours
Presenter: Ignacio Melero
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
1026MO - Phase Ib dose escalation study of novel immunogenic cell death (ICD) inducer PT-112 plus PD-L1 inhibitor avelumab in solid tumours
Presenter: Daniel Karp
Session: Mini Oral - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
365MO - Exploring changes in glioblastoma treatment patterns in Europe and the USA with population-based cancer registry data
Presenter: Francesco Giusti
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast
366MO - Incidence of malignant and non-malignant CNS tumours in Hong Kong
Presenter: Ka Man Cheung
Session: Mini Oral - CNS
Resources:
Abstract
Slides
Webcast